<DOC>
	<DOCNO>NCT00756158</DOCNO>
	<brief_summary>The ultimate goal study find specific polymorphism candidate gene associate endophenotypes and/or phenomenological phenotype ADHD . We propose replicate analysis candidate gene identify previous genetic study ADHD use candidate gene association study design ( family-based case control study use parental control ) validate finding research group . These result lead team : ( 1 ) resolve controversy inconsistent finding previous genetic study contribute literature validity ASD use clinical genetic data ; ( 2 ) study pathogenetic process abnormal gene abnormal neuropsychological neurobiological function ADHD ; ( 3 ) delineate nature effect gene-gene interaction etiology ADHD .</brief_summary>
	<brief_title>Molecular Studies Candidate Genes Dopaminergic Noradrenergic Systems ADHD</brief_title>
	<detailed_description>Attention deficit hyperactivity disorder ( ADHD ) , characterize inattention , hyperactivity impulsivity , early onset , highly heritable , clinically heterogeneous , long-term impair disorder tremendous impact individual , family , society . It affect 5-10 % school-aged child worldwide ( 7.5 % Taiwan ) 2-4 % adult . Neuropsychological deficit relate executive function , state regulation , delay aversion show heritability , replicate association ADHD , familial-genetic overlap ADHD , suitable biomarkers ADHD . Despite abundance molecular genetic study ADHD , genetic etiology ADHD non-conclusive , limited information expression , neuropsychological deficit , genetic variant ADHD Chinese population . This present study , family-based parental control association study , aim identify genetic marker dopaminergic noradrenergic system ADHD use dichotomous categorization affect non-affected , quantitative phenotype ( symptom dimension severity ADHD ) endophenotype ( neuropsychological measure ) well . Specific Aims : 1. determine component ADHD neuropsychological deficit great familial recurrence risk ; 2. replicate study positive genetic finding literature perform candidate gene analysis DRD4 , DRD2 , DRD5 , DAT1 , DBH , ADRA2C , ADRA1C , SLC6A2 ; 3. identify potential genetic variant use haplotype tagSNPs follow candidate gene , MAO-A ADRA2A update genetic finding . In addition sample 200 ADHD family ( 200 probands , 400 parent , 150 sibling ) recruit parallel study ( NSC96-2628-B-002-069 -MY3 ) , recruit another 100 probands ADHD , age 7-18 , parent ( n = 200 ) sibling ( n= 75 ) project . The phenotype measure include ( 1 ) interview psychopathology ( K-SADS-E ) social functioning ( SAICA ) , ( 2 ) self-administered questionnaire measure ADHD symptom ( SNAP-IV Adult ADHD rating scale ) comorbid condition ( ASRI CBCL ) , ( 3 ) Neuropsychological test : WISC-III , CPT , CANTAB , Time Perception Tasks . The DNA collect analyzed . The transmission/disequilibrium test ( TDT ) quantitative TDT use data analysis . We anticipate establishment clinical , neuropsychological , genetic database 300 ADHD family ( 200 NSC96-2628-B-002-069-MY3 100 project ) , completion screen several candidate gene , identification potential genetic variant ADHD , determination association ADHD diagnosis symptom endophenotype Taiwanese sample . The long-term objective identify behavioral phenotype endophenotypes close biological expression gene underlie ADHD . The finding different approach identify genetic etiology ADHD pilot study help u determine promise approach future molecular genetic pharmacogenetic study ADHD .</detailed_description>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Dopamine</mesh_term>
	<mesh_term>Dopamine Agents</mesh_term>
	<mesh_term>Dopamine Agonists</mesh_term>
	<criteria>The inclusion criterion proband subject That subject clinical diagnosis ADHD , Hyperkinetic Disorder define DSMIV ICD10 , respectively , make fulltime boardcertificated child psychiatrist first visit follow visit ; Their age range 7 18 conduct study ; Subjects least one biological parent ; Both parent Han Chinese ; Subjects biological parent ( sibling ) consent participate study complete phenotype assessment blood withdraw saliva collection genetic study . The proband subject exclude study currently meet criterion history follow condition define DSMIV : Schizophrenia , Schizoaffective Disorder , Organic Psychosis , Pervasive Developmental Disorder . Moreover , subject also exclude study completely cooperate blood withdrawal , collection saliva , buccal swab .</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>Attention Deficit Hyperactivity Disorder</keyword>
	<keyword>dopaminergic</keyword>
	<keyword>noradrenergic</keyword>
	<keyword>endophenotype</keyword>
	<keyword>molecular genetics</keyword>
	<keyword>candidate gene</keyword>
	<keyword>Family-based Association study</keyword>
</DOC>